WA
WST icon

WFG Advisors’s West Pharmaceutical WST Stock Holding History

WFG Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-46
Closed -$3K – 1824
2015
Q1 		$3K Hold
46
– – ﹤0.01% 1494
2014
Q4 		$2K Hold
46
– – ﹤0.01% 1884
2014
Q3 		$2K Buy
+46
New +$1.96K ﹤0.01% 1905

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

WFG Advisors's WST Position: Q2 2015 in Review

WFG Advisors sold out of West Pharmaceutical (WST) in Q2 2015, closing a stake of 46 shares — an estimated $3K sold.

WFG Advisors first reported a position in WST in Q3 2014 and held it in 3 quarters. The position peaked at $3K in Q1 2015. 219 funds tracked by Wall St. Rank hold WST as of Q2 2015.

  • WFG Advisors reported no remaining West Pharmaceutical position as of Q2 2015 after selling out during the quarter.
  • WFG Advisors sold 46 West Pharmaceutical shares in Q2 2015, an estimated $3K.
  • WFG Advisors first reported a position in West Pharmaceutical in Q3 2014 and held it in 3 quarters.
  • WFG Advisors's West Pharmaceutical position peaked at $3K in Q1 2015.
  • 219 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2015.

Based on WFG Advisors's 13F filing for Q2 2015, filed 13 Aug 2015.